Sleep Apnea Fighter Nyxoah Raises $20M

July 5, 2016 | Medical device company Nyxoah, which has developed a solution for obstructive sleep apnea, reports that they have raised raising $20 million in funding. The company was established by Robert Taub, founder of Omrix Biopharmaceuticals, which was sold to Johnson & Johnson for $438 million in 2008. While Nyxoah was founded in Belgium, its R&D activity is situated in Israel and employs 15 out of the company’s staff of 25. Taub is Nyxoah’s CEO, in addition to being an investor and co-founder.